0001808805-22-000093.txt : 20220816
0001808805-22-000093.hdr.sgml : 20220816
20220816201919
ACCESSION NUMBER: 0001808805-22-000093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220812
FILED AS OF DATE: 20220816
DATE AS OF CHANGE: 20220816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy Matthew B.
CENTRAL INDEX KEY: 0001865778
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 221171812
MAIL ADDRESS:
STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC.
STREET 2: 425 PONTIUS AVE N, STE 202
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
4
1
wf-form4_166069554291105.xml
FORM 4
X0306
4
2022-08-12
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001865778
Murphy Matthew B.
C/O NAUTILUS BIOTECHNOLOGY, INC.
2701 EASTLAKE AVENUE EAST
SEATTLE
WA
98102
0
1
0
0
General Counsel
Common Stock
2022-08-12
4
P
0
2500
2.85
A
46640
I
See Footnote
Common Stock
2022-08-15
4
P
0
7500
2.841
A
54140
I
See Footnote
Common Stock
1250
D
Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.
1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.
/s/ Matthew B. Murphy
2022-08-16